Table 2.
Groups | SCFAs (μg/g) | ||||||
---|---|---|---|---|---|---|---|
Acetic Acid | Propanoic Acid | Isobutyric Acid | Butyric Acid | Isovaleric Acid | Valeric Acid | Caproic Acid | |
NC | 995.89 ± 80.17 b | 220.89 ± 21.03 b | 25.86 ± 1.64 a | 365.12 ± 88.77 a | 20.45 ± 2.16 a | 42.29 ± 1.87 a | 1.48 ± 0.51 a |
MC | 1307.18 ± 101.68 a | 290.96 ± 34.29 a | 13.76 ± 0.40 b | 139.97 ± 23.48 b | 10.60 ± 0.28 b | 31.38 ± 1.48 b | 0.82 ± 0.17 b |
SASP | 918.04 ± 137.65 b | 250.71 ± 25.97 ab | 16.44 ± 2.26 b | 179.87 ± 29.07 b | 12.29 ± 0.59 b | 27.73 ± 0.56 b | 0.80 ± 0.05 b |
L-STE | 907.52 ± 171.62 b | 269.21 ± 12.53 a | 16.54 ± 1.62 b | 301.65 ± 22.48 a | 11.92 ± 1.08 b | 32.92 ± 2.22 b | 0.84 ± 0.03 b |
H-STE | 879.19 ± 121.77 b | 286.76 ± 27.32 a | 14.91 ± 2.07 b | 315.01 ± 27.28 a | 11.63 ± 0.76 b | 29.25 ± 6.62 b | 0.84 ± 0.07 b |
Abbreviations: NC, normal control group; MC, DSS-induced UC model group; SASP, suffasalarin intervention group at the dose of 100 mg/kg; L-STE, STE intervention group at the dose of 100 mg/kg; H-STE, STE intervention group at the dose of 400 mg/kg. Data are expressed as the mean ± the SD (n = 10) and analyzed by one-way ANOVA followed by Duncan’s multiple comparisons test. The different superscript lowercase letters in the same column indicate statistical significance (p < 0.05).